The Institute of Cell Therapy participated in the conference “Technical Advancement on the Service to Medicine”

Cell therapy and biotechnologies are the most rapidly developing medical fields, and the therapeutic capabilities today are directly proportional to scientific and technological progress. After all, the isolation of stem cells from the biological material, f.i. cord blood, placenta, umbilical cord or other tissues, their further cultivation, investigations, cryopreservation, laboratory monitoring of the effectiveness of therapy require high-tech equipment. And the material and technical base of the Ukraine’s only ISO-accredited Cryobank of the Institute of Cell Therapy allows our Clinic to keep up with the world science.

 

May 29 – June 1, 2019, Gdansk, Poland hosted the international scientific conference “Technical Advancement on the Service to Medicine”, in which both leading scientists and practitioners from all over the world (the USA, Australia, the countries of the Western and Eastern Europe) took part. The scientific associates of the Institute of Cell Therapy also took an active part in the work of the Congress, having presented a paper, devoted to the application of modern histochemical and immunohistochemical methods of research in the study of biological tissues.

 

Among the hot issues of the conference were considered the problems of nanomedicine, oncology, cell technologies, medical ethics and history of medicine, personalized medicine, based on the study of the genome.

 

Proceedings of the conference were published in the international peer-reviewed journal “Wiadomosci Lekarskiе”, which is included in such prestigious scientiometric databases as Scopus and Pubmed.

 

Speakers of the conference noted that technological advances in medicine within the last decade have fundamentally changed the approaches to the diagnosis and treatment of a number of socially important diseases, in particular through the use of cell technologies and nanomedicine, greatly improving the therapeutic options and quality of life of patients.

 

The Institute of Cell Therapy is a member of the International Society for Cell Therapy (ISCT), the International Society for Placenta Stem Cells (IPLASS) and the International Federation of Placenta Associations (IFPA). The Institute of Cell Therapy is also a joint contractor of a number of international scientific projects, including the COST action CA17116 for the evaluation of placenta stem cells, funded by the European Cooperation for Science and Technology within the Horizon 2020 program.

Feedback
Call or email us for more information

    Contact us